Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Central pontine myelinolysis

*


* Not a rare disease
Other Names for this Disease
  • CPM
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment


Clinical Trials & Research for this Disease

  • The National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. While no studies involving central pontine myelinolysis specifically are listed at this time, there are a number of studies enrolling patients with hyponatraemia (low sodium). To find these trials, click here. After you click on a study, review its "eligibility" criteria to determine its appropriateness. Use the study’s contact information to learn more. Check this site often for regular updates.

    You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling the toll-free number listed below to speak with a specialist, who can help you determine if you are eligible for any clinical trials.

    Patient Recruitment and Public Liaison Office (PRPL)
    NIH Clinical Center
    Bethesda, Maryland 20892-2655
    Toll-free: 1-800-411-1222
    Fax: 301-480-9793
    E-mail: prpl@mail.cc.nih.gov
    Web site:  http://clinicalcenter.nih.gov/

    If you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials at the following ClinicalTrials.gov Web page.
    http://clinicaltrials.gov/ct2/info/understand

    Resources on many charitable or special-fare flights to research and treatment sites and low-cost hospitality accommodations for outpatients and family members, as well as ambulance services, are listed on the Web site of the Office of Rare Diseases Research (ORDR), part of the National Institutes of Health.
    http://rarediseases.info.nih.gov/Resources.aspx?PageID=8

  • The Research Portfolio Online Reporting Tool (RePORT) provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  There is a study involving central pontine myelinolysis in individuals with an alcohol addiction titled In Vivo Diffusion and Spectroscopic Brain Imaging in Alcoholism. Click on the study title to view the study description. You can contact the study investigator Adolf Pfefferbaum at dolf@synapse.sri.com to learn more. You can search RePORT periodically for regular updates.